People · Operator
Named in public records as an officer, director or promoter · active 2024–2026 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Navigator Medicines, Inc. | — | Biotechnology | Series C | $50.0M | $422.0M | 2024 |
| Lonestar Medicines, Inc. | — | Biotechnology | Series B | $25.0M | $92.4M | 2026 |
Andrew Manu Levin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Manu Levin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Naveen Manu Daryani | 2 | 2 |
| William Daley Bonificio | 2 | 2 |
| Stephen Basil Thomas | 2 | 2 |
| Gianna Manu Hoffman-Luca | 1 | 1 |
| WOUTER MANU JOUSTRA | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.